Meridian Bioscience Reports Third Quarter 2019 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- Wall Street ends down as US-Iran peace optimism fades
- eToro to acquire TradeZero for up to $231M to expand in US
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Meridian Bioscience (VIVO) Tops Q3 EPS by 7c, Revenues Miss; Offers FY19 EPS Guidance
July 30, 2019 7:35 AM EDTMeridian Bioscience (NASDAQ: VIVO) reported Q3 EPS of $0.16, $0.07 better than the analyst estimate of $0.09. Revenue for the quarter came in at $48.4 million versus the consensus estimate of $49.81 million.
Third Quarter 2019 Highlights (Comparison to Third Quarter Fiscal 2018):
Consolidated revenue decreased 6% to $48.4 million (5% decrease in constant-currency)Diagnostics segment revenues decreased 9% to $33.1 million (8% decrease in constant-currency)Life Science segment revenues were flat at $15.3 million (1% growth in constant-currency)Reported GAAP operating income of $6.5 million (including $2.5 million of costs associated with acquisition activities, restructuring activities and selected legal proceedings), as compared to $8.7 million last... More